Drreddys Laboratories reported INR24.64B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
ANI Pharmaceuticals USD 54.08M 5.72M Jun/2025
Aurora Cannabis CAD -11427000 13.94M Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Canopy Growth CAD -21827000 13.2M Jun/2025
Cipla INR 17.78B 2.41B Jun/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Drreddys Laboratories INR 24.64B 1.33B Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 139M Dec/2024
Novartis USD 6.17B 339M Jun/2025
Pacira USD 54.32M 24.98M Jun/2025
Prestige Brands USD 79.65M 28.5M Jun/2025
Richter Gedeon HUF 75.72B 6.71B Sep/2024
Sun Pharmaceuticals INR 39.48B 5.23B Jun/2025
Supernus Pharmaceuticals USD 41.47M 23.68M Jun/2025
Teva Pharmaceutical Industries USD 1.23B 124M Jun/2025